BGM BGM Group Corp Net earnings per share (EPS TTM)

BGM Group Ltd maintains its positions in niche segments through patents, which eliminates price wars. The 12-month rolling earnings per share history demonstrates the asset's dynamics, where the indicator value reaches -4.81. The business relies on Chinese heparin production plants; however, high development costs and the risk of failed tests create financial threats.
Analytical breakdowns for BGM Group Corp (BGM)

Specialized pharma logistics provider BGM Group Ltd (BGM) minimizes drug shortages through redundant delivery routes, ensuring stable operating margins. This TTM earnings per share figure aggregates net income over four quarters and distributes it across the total shares outstanding to assess the real return per share, allowing investors to filter out market noise and determine the asset's fundamental value.